Literature DB >> 11298589

Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: a multiparameter flow cytometry study.

Y Xu1, S H Kroft, R W McKenna, D B Aquino.   

Abstract

Tumour-infiltrating T lymphocytes (TIL-T) have been implicated in playing a role in controlling tumour growth. We evaluated TIL-T in 55 cases of de novo diffuse large B-cell lymphoma (DLBCL) using three- or four-colour flow cytometric immunophenotyping (FCI). The percentage of TIL-T varied from 3% to 72% of total viable cellular events (mean 32 +/- 20%). The CD4:CD8 ratio varied from 0.17 to 13 (mean 2.3 +/- 2.2). Cases with >/= 20% T cells and those with CD4:CD8 ratios > or = 2.0 showed a significantly better overall survival (P = 0.017 and P = 0.034 respectively). These findings were independent of clinical stage at diagnosis. The T-cell percentage and CD4:CD8 ratio were moderately correlated (Spearman correlation coefficient = 0.47, P = 0.001) and multivariate analysis revealed that the association of the two factors with prognosis was mutually dependent. The T cells in 23 cases were studied for CD45RO. The mean percentage of total T cells expressing CD45RO was 86 +/- 10%. There was a trend towards better survival for those patients with a higher percentage of CD45RO+ T cells (P = 0.06). These results suggest that TIL-T, particularly CD4+ T cells, may play a role in the control of DLBCL, and measurement of T-cell percentage and T-cell subsets using FCI may be useful in predicting the clinical behaviour of DLBCL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11298589     DOI: 10.1046/j.1365-2141.2001.02649.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Prognostic significance of T cell subsets in peripheral blood of B cell non-Hodgkin's lymphoma patients.

Authors:  Mehdi Dehghani; Shokouh Sharifpour; Zahra Amirghofran; Hamid Reza Zare
Journal:  Med Oncol       Date:  2012-02-04       Impact factor: 3.064

2.  T cells, mast cells and microvascular density in diffuse large B cell lymphoma.

Authors:  Christian Marinaccio; Giuseppe Ingravallo; Francesco Gaudio; Tommasina Perrone; Simona Ruggieri; Giuseppina Opinto; Beatrice Nico; Eugenio Maiorano; Giorgina Specchia; Domenico Ribatti
Journal:  Clin Exp Med       Date:  2015-05-10       Impact factor: 3.984

3.  Inhibition of STAT3 activity re-activates anti-tumor immunity but fails to restore the immunogenicity of tumor cells in a B-cell lymphoma model.

Authors:  Yang Cao; Xiaoxi Zhou; Mi Zhou; Danmei Xu; Quanfu Ma; Peilin Zhang; Xiaoyuan Huang; Qinlu Li; Ding Ma; Jianfeng Zhou
Journal:  Cancer Biol Ther       Date:  2014-06-10       Impact factor: 4.742

4.  Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma.

Authors:  Wanjun Chen; Weijie Liang; Yongjian He; Chixiang Liu; Hongtian Chen; Piao Lv; Yuan Yao; Huayou Zhou
Journal:  Med Oncol       Date:  2022-01-29       Impact factor: 3.064

5.  Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma.

Authors:  Liping Song; Tasnim Ara; Hong-Wei Wu; Chan-Wook Woo; C Patrick Reynolds; Robert C Seeger; Yves A DeClerck; Carol J Thiele; Richard Sposto; Leonid S Metelitsa
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

6.  Mutations in the HLA class II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphoma.

Authors:  Ekaterina S Jordanova; Katja Philippo; Marius J Giphart; Ed Schuuring; Philip M Kluin
Journal:  Immunogenetics       Date:  2003-05-17       Impact factor: 2.846

7.  Prognostic Role of Tumor Microenvironment in DLBCL and Relation to Patients' Clinical Outcome: A Clinical and Immunohistochemical Study.

Authors:  Doaa Shams-Deen Ghorab; Ahmed Mohamed Helaly; Hoda Saleh El Mahdi; Moawiah Khatatbeh; Afaf Taha Ibrahiem
Journal:  Anal Cell Pathol (Amst)       Date:  2022-01-17       Impact factor: 2.916

8.  Immune suppression in tumors as a surmountable obstacle to clinical efficacy of cancer vaccines.

Authors:  Grégoire Wieërs; Nathalie Demotte; Danièle Godelaine; Pierre Van der Bruggen
Journal:  Cancers (Basel)       Date:  2011-07-18       Impact factor: 6.639

Review 9.  The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells.

Authors:  Giuseppe Ingravallo; Roberto Tamma; Giuseppina Opinto; Tiziana Annese; Francesco Gaudio; Giorgina Specchia; Tommasina Perrone; Pellegrino Musto; Gerardo Cazzato; Emilio Bellitti; Saverio Capodiferro; Eugenio Maiorano; Domenico Ribatti
Journal:  Diagnostics (Basel)       Date:  2022-02-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.